Economists would describe the U.S. market for patented pharmaceuticals as
Group of answer choices:
purely competitive.
a pure monopoly.
an oligopoly.
monopolistically competitive.
The Correct Answer and Explanation is:
Correct Answer: A pure monopoly.
The U.S. market for patented pharmaceuticals is best described as a pure monopoly due to the unique legal protections and market conditions that exist when a pharmaceutical company holds a patent on a drug.
Explanation:
When a pharmaceutical company develops a new drug, it typically receives a patent from the U.S. government. This patent grants the company exclusive rights to produce and sell the drug for a specific period (typically 20 years from the date of patent application). During this time, no other firm is legally allowed to manufacture or sell a generic version of the same drug. As a result, the company becomes the sole producer and seller of that particular pharmaceutical product. This exclusivity gives the company monopoly power over the pricing and distribution of the drug.
This situation matches the characteristics of a pure monopoly, which include:
- A single seller of a unique product.
- High barriers to entry, which in this case include patent laws, FDA approval processes, and high R\&D costs.
- The firm is a price maker, meaning it has the power to set prices without immediate competition.
- The product has no close substitutes during the life of the patent.
While the broader pharmaceutical industry may exhibit traits of oligopoly (a few major firms dominating), the market for each patented drug functions as a monopoly during the patent period. After the patent expires, generic drug manufacturers can enter the market, increasing competition and often drastically reducing prices.
In summary, economists describe the market for patented pharmaceuticals as a pure monopoly due to legal protections that grant exclusive selling rights to a single firm, effectively eliminating competition for that drug during the patent term.